Insider Stock Trading History of Goldberg Y. Paul


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Goldberg Y. Paul since year 2005. The trader's CIK number is 1619960. At the time of this reporting, Goldberg Y. Paul is the VP of Clinical Development of Xenon Pharmaceuticals Inc. . (stock ticker symbol XENE). See this page for all insider trading activities at Xenon Pharmaceuticals Inc. .


Stock purchases, sales, and option exercises reported by insider Goldberg Y. Paul since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-09-24 XENE Xenon Pharmaceuticals Inc. Sale 12,000 8.60 103,200
2015-09-23 XENE Xenon Pharmaceuticals Inc. Sale 4,000 9.02 36,080
2015-09-22 XENE Xenon Pharmaceuticals Inc. Sale 6,149 9.33 57,382
2015-09-22 XENE Xenon Pharmaceuticals Inc. Option Ex 30,388 3.49 106,145
2015-08-18 XENE Xenon Pharmaceuticals Inc. Option Ex 3,085 4.90 15,101

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Goldberg Y. Paul (VP of Clinical Development of Xenon Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.